Evidence map›Paper›PMID 42328854›Full record

ArticleCancer research2026

Longitudinal Single-Cell RNA-Sequencing Reveals Evolution of Micro- and Macro-states in Chronic Myeloid Leukemia.

David E Frankhouser, Dandan Zhao, Yu-Hsuan Fu, Anupam Dey, Ziang Chen, Jihyun Irizarry, Jennifer Rangel Ambriz, Tiffany Kanesa Ybarra, Sergio Branciamore, Denis O'Meally and 9 more

Abstract read
In one paragraph

Article in Cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Longitudinal omics data analysis: approaches and applications.Computational and structural biotechnology journal · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

David E FrankhouserCity Of Hope National Medical Center Duarte, CA United States.ORCID 0000-0002-8233-5853
Dandan ZhaoCity Of Hope National Medical Center United States.ORCID 0009-0002-3639-4024
Yu-Hsuan FuCity Of Hope National Medical Center Duarte United States.ORCID 0000-0002-5917-2961
Anupam DeyUniversity of Southern California Los Angeles, CA United States.ORCID 0000-0002-9071-8774
Ziang ChenCity Of Hope National Medical Center Duarte, CA United States.ORCID 0009-0001-4153-7563
Jihyun IrizarryCity Of Hope National Medical Center United States.ORCID 0000-0003-3967-2288
Jennifer Rangel AmbrizCity Of Hope National Medical Center United States.ORCID 0009-0002-5363-3576
Tiffany Kanesa YbarraStanford University Stanford, CA United States.ORCID 0000-0002-5409-4984
Sergio BranciamoreCity Of Hope National Medical Center Duarte United States.ORCID 0000-0002-2556-8765
Denis O'MeallyCity Of Hope National Medical Center Duarte, California United States.ORCID 0000-0001-7749-9506
Ryan S SathianathenStanford University Stanford, CA United States.ORCID 0009-0001-1660-9975
Jeffrey M TrentTranslational Genomics Research Institute Phoenix, AZ United States.ORCID 0000-0003-0183-4202
Stephen J FormanCity Of Hope National Medical Center Duarte, CA United States.ORCID 0000-0002-2803-4152
Adam L MacLeanUniversity of Southern California Los Angeles United States.ORCID 0000-0003-0689-7907
Ya-Huei KuoCity Of Hope National Medical Center Duarte, CA United States.ORCID 0000-0003-2595-0419
Kathleen M SakamotoStanford University Stanford, CA United States.ORCID 0000-0003-0494-8838
Bin ZhangCity Of Hope National Medical Center Duarte, CA United States.ORCID 0000-0003-4703-7524
Russell C RockneCity Of Hope National Medical Center Monrovia, California United States.ORCID 0000-0002-1557-159X
Guido MarcucciCity Of Hope National Medical Center Columbus, OH United States.ORCID 0000-0002-3983-5908

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3M
Information flow and state transitions at the system and multi-dimensional scales in leukemia progressionU01CA250046 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KUO, YA-HUEI, MARCUCCI, GUIDO · 2020 to 2024
$3.6M
Computational methods to predict gene regulatory network dynamics and cell state transitionsR35GM143019 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MACLEAN, ADAM L · 2021 to 2025
$2.1M
State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapyU01CA293853 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI YA-HUEI KUO, GUIDO MARCUCCI · 2024 to 2026
$1.8M
Targeting Immune Escape in CML/MPN TransformationR01CA286160 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI GUIDO MARCUCCI, BIN ZHANG · 2024 to 2026
$1.7M
NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA286160NCI NIH HHS U01 CA250046NCI NIH HHS U01 CA293853NIGMS NIH HHS R35 GM143019
6 · The paper itself

Abstract

Single-cell RNA-sequencing (scRNA-seq) has revolutionized our understanding of cancer. However, identifying meaningful disease states from single-cell data remains challenging due to the complex continuum of transcriptional alterations, which may obscure clear phenotype boundaries and complicate biological interpretation and clinical relevance. Here, we systematically explored the chronic myeloid leukemia (CML) specific information content encoded in scRNA-seq versus bulk transcriptomics to resolve this paradox and clarify how discrete disease-defining states emerge from inherently noisy single-cell data. While CML single-cell transcriptomes existed along continuous transcriptional micro-states, clinically relevant leukemia phenotypes clearly manifested only at the pseudobulk (macro-state) level. State-transition theory was leveraged to reveal how disease phenotype state-transitions are governed by cell type specific contributions. Together, these results establish a theoretical framework explaining why discrete disease phenotypes remain hidden at the single-cell scale but emerge clearly at the aggregated macro-state level, enabling previously inaccessible biological insights into leukemia evolution. By resolving how single-cell variation aggregates into macroscopic disease states, this framework provides insights into CML progression and offers a broadly applicable strategy for exploring disease dynamics across cancers and other complex conditions.

Identifiers

PMID42328854
PMCPMC13679914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.